Novel Anti-Mesothelin Nanobodies and Recombinant Immunotoxins with <i>Pseudomonas</i> Exotoxin Catalytic Domain for Cancer Therapeutics. | Mol Cells;46(12): 764-777, 2023 Dec 31. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Novel Anti-Mesothelin Nanobodies and Recombinant Immunotoxins with Pseudomonas Exotoxin Catalytic Domain for Cancer Therapeutics.

Nguyen, Minh Quan; Kim, Do Hyung; Shim, Hye Ji; Ta, Huynh Kim Khanh; Vu, Thi Luong; Nguyen, Thi Kieu Oanh; Lim, Jung Chae; Choe, Han.

Mol Cells ; 46(12): 764-777, 2023 Dec 31.

Article in En | MEDLINE | ID: mdl-38052492

Subject(s)
Key words

PE24B; cancer therapeutics; cytotoxic efficacy; mesothelin-targeting; nanobody-based recombinant immunotoxin

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Immunotoxins / Single-Domain Antibodies / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Mol Cells Journal subject: BIOLOGIA MOLECULAR Year: 2023 Document type: Article Country of publication: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Immunotoxins / Single-Domain Antibodies / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Mol Cells Journal subject: BIOLOGIA MOLECULAR Year: 2023 Document type: Article Country of publication: Estados Unidos